103 related articles for article (PubMed ID: 38741164)
1. Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study.
Acar SO; Tahta N; Al IO; Erdem M; Gözmen S; Karapınar TH; Kılınç B; Celkan T; Kirkiz S; Koçak Ü; Ören H; Yıldırım AT; Arslantaş E; Ayhan AC; Oymak Y
Scand J Immunol; 2024 May; ():e13376. PubMed ID: 38741164
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.
Zhang Z; Hu Q; Yang C; Chen M; Han B
Ann Med; 2023; 55(2):2282180. PubMed ID: 37967535
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.
Jasinski S; Weinblatt ME; Glasser CL
J Pediatr Hematol Oncol; 2017 Aug; 39(6):420-424. PubMed ID: 28267088
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Bride KL; Vincent T; Smith-Whitley K; Lambert MP; Bleesing JJ; Seif AE; Manno CS; Casper J; Grupp SA; Teachey DT
Blood; 2016 Jan; 127(1):17-28. PubMed ID: 26504182
[TBL] [Abstract][Full Text] [Related]
6. Maintenence rituximab following induction in autoimmune cytopenias.
Rai MP; Lee EJ; Bussel JB
Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus is effective in relapsed/refractory autoimmune cytopenias: results of a single-center retrospective study.
Du Y; Yang C; Chen M; Ruan J; Huang Y; Chen F; Han B
Hematology; 2020 Dec; 25(1):478-483. PubMed ID: 33297889
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study.
Feng Y; Xiao Y; Yan H; Wang P; Zhu W; Cassady K; Zou Z; Wang K; Chen T; Quan Y; Wang Z; Yang S; Wang R; Li X; Gao L; Zhang C; Liu Y; Kong P; Gao L; Zhang X
Front Med (Lausanne); 2020; 7():110. PubMed ID: 32296709
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.
Miano M; Scalzone M; Perri K; Palmisani E; Caviglia I; Micalizzi C; Svahn J; Calvillo M; Banov L; Terranova P; Lanza T; Dufour C; Fioredda F
Br J Haematol; 2015 Oct; 171(2):247-253. PubMed ID: 26058843
[TBL] [Abstract][Full Text] [Related]
11. [Not Available].
Hbibi M; El Alaoui El Hanafi M; Kasmi Z; Ouair H; Benmiloud S; Ailal F; Hida M; Bousfiha AA
Tunis Med; 2024 Jan; 102(1):1-6. PubMed ID: 38545722
[TBL] [Abstract][Full Text] [Related]
12. [Outcomes of splenectomy in relapsed/refractory autoimmune hemolytic anemia].
Fan SB; Wang ZJ; Mao Q; Tong CF; Zhai WT; Zheng YZ; Sun CX; Shi J
Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):132-136. PubMed ID: 30831628
[No Abstract] [Full Text] [Related]
13. Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database.
Martin M; Nguyen HM; Beuvon C; Bene J; Palassin P; Atzenhoffer M; Rouby F; Sassier M; Pérault-Pochat MC; Roblot P; Allouchery M; Puyade M;
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291814
[TBL] [Abstract][Full Text] [Related]
14. Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study.
Feng Y; Meng H; Mu C; Zhang Y; Liu X; Shi Y; Wang H
Blood Coagul Fibrinolysis; 2024 Jun; 35(4):155-160. PubMed ID: 38625834
[TBL] [Abstract][Full Text] [Related]
15. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
[TBL] [Abstract][Full Text] [Related]
16. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
17. Haematopoietic stem cell transplantation for immune thrombopenia and other refractory autoimmune cytopenias.
Passweg JR
Best Pract Res Clin Haematol; 2004 Jun; 17(2):305-15. PubMed ID: 15302342
[TBL] [Abstract][Full Text] [Related]
18. Expanded utilization of rituximab in paediatric cardiac transplant patients.
Kiskaddon AL; Landmesser K; Carapellucci J; Wisotzkey B; Asante-Korang A
J Clin Pharm Ther; 2021 Jun; 46(3):762-766. PubMed ID: 33393702
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
Liu H; Ding K; Zhang W; Xing L; Wang Y; Wang H; Song J; Li L; Fu R
Br J Haematol; 2024 Mar; 204(3):1082-1085. PubMed ID: 37932927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
